Glycostem CEO Troels Jordansen shares updates from Glycostem at Alliance for Regenerative Medicine’s 2020 Cell & Gene Virtual Meeting on the Mesa.

On 8^th October 2020, Glycostem participates 2020 ISPE Biotechnology Virtual Conference. Glycostem CDO Volker Huppert presents our GMP manufacturing method of an off-the-shelf cell therapy product.

Glycostem participates the CBIIC (China BioMed Innovation and Investment Conference) virtual roadshow on 21^st Sep 2020. Our CEO Troels Jordansen talks about the our company, pipelines and the forward-looking prospects of Glycostem.

Glycostem presents virtually at Innate Killer Summit 2020 our production system for off-the-Shelf, GMP Compliant, fully closed & semi-automated large-scale (oNKord^®) from fresh umbilical cord blood stem cells.

Glycostem is honored being seleced to be part of SVB Leerink Biopharma Private Company Connect on 7^th to 9^th July. It is a series of 1:1 between investors and Glycostem, one of the last formally organized investor conferences before the European summer break.

Glycostem CEO Troels Jordansen presents on 25^th June at the upcoming Virtual European Biotech Investor Day 2020 hosted by Solebury Trout, Goodwin, Deutsche Bank and Nasdaq.